patients with advanced or metastatic esophageal cancer (EC). Materials and methods We
identified 71 patients (33 adenocarcinoma [AC] and 38 squamous cell carcinoma [ESCC])
with unresectable or metastatic EC who had PET/CT prior to palliative treatment. Volumetric
parameters (metabolic tumor volume [MTV], total lesion glycolysis [TLG], tumor length [TL])
as well as maximum and mean standardized uptake (SUVmax, SUVmean) were obtained …